Fig. 5
From: Simvastatin induced ferroptosis for triple-negative breast cancer therapy
Biodistribution of Fe3O4 and Fe3O4 @PCBMA nanoparticles after 24 h injection (A); In vivo blood retention profiles of Fe3O4 and Fe3O4@PCBMA nanoparticles (1 mg/mL, 100 μL) (B); Tumor growth curves and body weight changes of nanomedicine. Treatments were performed on day 0, 3, 6 and 9. Error bars indicate the SD (n = 5) (C, D); Photographs (left) and weights (right) of tumors after therapy (E) *P < 0.05 **P < 0.01 ***P < 0.001